Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis

Frontiers in Microbiology
Diana MachadoMarco Pieroni

Abstract

The emergence of multi- and extensively drug resistant tuberculosis worldwide poses a great threat to human health and highlight the need to discover and develop new, effective and inexpensive antituberculosis agents. High-throughput screening assays against well-validated drug targets and structure based drug design have been employed to discover new lead compounds. However, the great majority fail to demonstrate any antimycobacterial activity when tested against Mycobacterium tuberculosis in whole-cell screening assays. This is mainly due to some of the intrinsic properties of the bacilli, such as the extremely low permeability of its cell wall, slow growth, drug resistance, drug tolerance, and persistence. In this sense, understanding the pathways involved in M. tuberculosis drug tolerance, persistence, and pathogenesis, may reveal new approaches for drug development. Moreover, the need for compounds presenting a novel mode of action is of utmost importance due to the emergence of resistance not only to the currently used antituberculosis agents, but also to those in the pipeline. Cheminformatics studies have shown that drugs endowed with antituberculosis activity have the peculiarity of being more lipophilic than many other...Continue Reading

References

Dec 1, 1979·Chest·D A Mitchison
May 1, 1979·Journal of Medicinal Chemistry·K C AgrawalW D Rupp
Jun 1, 1979·Leprosy Review·S J Yawalkar, W Vischer
Jan 1, 1989·Annual Review of Biochemistry·J A Endicott, V Ling
Sep 1, 1965·Journal of Medicinal Chemistry·R T RapalaK Gerzon
Jun 24, 1967·Nature·P Mitchell
Jul 1, 1983·Reviews of Infectious Diseases·P Sensi
Oct 15, 1994·FEMS Microbiology Letters·V Jarlier, H Nikaido
Feb 1, 1993·Antimicrobial Agents and Chemotherapy·D R AshtekarW Rittel
Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·C M SassettiE J Rubin
May 31, 2002·Journal of Medicinal Chemistry·Daniel F VeberKenneth D Kopple
Jun 5, 2002·Toxicology Letters·Gisell Rodriguez FerreiroMarta Ana Carballo
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Miguel ViveirosLeonard Amaral
Jun 18, 2003·Parasitology Research·W Raether, H Hänel
Nov 1, 1963·Journal of Medicinal Chemistry·K GERZONM A ROOT
Nov 1, 2003·The Journal of Infectious Diseases·Peter SeilerPeter Aichele
Nov 17, 2004·Current Pharmaceutical Design·Clifton E BarryCynthia S Dowd
Mar 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Edward A WeinsteinHarvey Rubin
May 24, 2005·Infection and Immunity·Pilar DomenechClifton E Barry
Jun 9, 2005·Advanced Drug Delivery Reviews·Ayush Kumar, Herbert P Schweizer
Jun 25, 2005·Current Drug Metabolism·Amit S KalgutkarShawn P Harriman
Sep 21, 2005·The Journal of Antimicrobial Chemotherapy·Marina ProtopopovaCarol A Nacy
Jan 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ujjini H ManjunathaClifton E Barry
Apr 15, 2006·Clinical Microbiology Reviews·Laura J V Piddock
May 26, 2006·Journal of Medicinal Chemistry·Elena BogatchevaMarina Protopopova
Jun 6, 2006·The Journal of Antimicrobial Chemotherapy·Ping ChenCarol A Nacy
Jul 4, 2006·Current Opinion in Chemical Biology·Thomas H KellerZheng Yin
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·Stephanie PetrellaWladimir Sougakoff
Nov 1, 2006·Current Drug Metabolism·Urs A BoelsterliKoon Yeow Leow
Nov 10, 2006·The Journal of Biological Chemistry·Boris A FenioukMasasuke Yoshida
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·John Cl Erve
Dec 13, 2006·Nature Reviews. Drug Discovery·David J PayneDavid L Pompliano
Dec 22, 2006·Journal of Medicinal Chemistry·Hirofumi SasakiHidetsugu Tsubouchi

❮ Previous
Next ❯

Citations

May 10, 2020·Journal of Molecular Modeling·Clement AgoniMahmoud E Soliman
Sep 6, 2020·Antibiotics·Marta Filipa SimõesAndré Antunes
Apr 30, 2019·Expert Review of Proteomics·Deepa BishtVivek Kumar Gupta
Dec 18, 2020·Frontiers in Chemistry·Pedro F DalbertoLuiz A Basso
Feb 25, 2020·Tuberculosis·Jean Eduardo MeneguelloRosilene Fressatti Cardoso
Jun 12, 2020·European Journal of Medicinal Chemistry·Maria Giulia NiziOriana Tabarrini
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Richard M BeteckSetshaba D Khanye
Feb 28, 2021·Chemical Biology & Drug Design·Shahinda S R AlsayedHendra Gunosewoyo
May 1, 2021·Pharmaceutics·Filia StephanieUsman Sumo Friend Tambunan
Apr 27, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hans-Peter GrobbelStefan Niemann
Sep 1, 2021·ACS Biomaterials Science & Engineering·Chee Wei AngMark A T Blaskovich
Nov 12, 2021·Molecular Diversity·Mushtaq Ahmad Wani, Devendra Kumar Dhaked
Dec 15, 2021·Mathematical Biosciences and Engineering : MBE·Rishin Haldar, Swathi Jamjala Narayanan
Nov 30, 2021·Disease Models & Mechanisms·Nils-Jørgen Knudsen DalNoelia Alonso-Rodriguez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.